TLR9 and ischemia: In the present study, global ischemia was performed in an ex vivo model to eliminate the contribution of circulating immune cells, showing that ablation of Tlr9 had no effect on cardiac function during ischemia, but improved recovery of both systolic and diastolic cardiac function during reperfusion.